Lyra Therapeutics, Inc. (LYRA)
NASDAQ: LYRA · Real-Time Price · USD
0.184
+0.006 (3.09%)
Nov 21, 2024, 2:58 PM EST - Market open

Lyra Therapeutics Stock Forecast

LYRA's stock price has decreased by -93.71% in the past year and price targets may not have had time to catch up.

Stock Price Forecast

The 3 analysts with 12-month price forecasts for Lyra Therapeutics stock have an average target of 4.50, with a low estimate of 0.50 and a high estimate of 11. The average target predicts an increase of 2,352.32% from the current stock price of 0.18.

Analyst Consensus: Buy
Target Low Average Median High
Price $0.50 $4.50 $2.00 $11
Change +172.48% +2352.3% +989.92% +5894.6%
* Price targets were last updated on Aug 15, 2024.

Analyst Ratings

The average analyst rating for LYRA stock from 5 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating Jun '24Jul '24Aug '24Sep '24Oct '24Nov '24
Strong Buy 111111
Buy 111111
Hold 333333
Sell 000000
Strong Sell 000000
Total 555555

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
Cantor Fitzgerald
Cantor Fitzgerald
Buy
Reiterates
n/a
Buy Reiterates n/a n/a Aug 15, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Hold
Reiterates
$2
Hold Reiterates $2 +989.92% Aug 15, 2024
Cantor Fitzgerald
Cantor Fitzgerald
Buy
Reiterates
n/a
Buy Reiterates n/a n/a Jun 20, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Hold
Downgrades
$2
Hold Downgrades $2 +989.92% May 7, 2024
Jefferies
Jefferies
Hold
Downgrades
$10$0.5
Hold Downgrades $10$0.5 +172.48% May 7, 2024
More Analyst Ratings

Financial Forecast

Revenue This Year
1.78M
from 1.56M
Increased by 13.99%
Revenue Next Year
717.88K
from 1.78M
Decreased by -59.58%
EPS This Year
-1.36
from -1.26
EPS Next Year
-0.76
from -1.36
Fiscal Year FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026
Period Ending Dec 31, 2019 Dec 31, 2020 Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026
Revenue
--285.00K1.36M1.56M1.78M717.88K8.12M
Revenue Growth
---378.25%14.31%13.99%-59.58%1,030.84%
EPS
-82.23-2.59-3.35-1.83-1.26-1.36-0.76-0.71
EPS Growth
--------
Forward PE
--------
No. Analysts -----776
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 20242025202620272028
High 2.4M 1.7M 19.8M
Avg 1.8M 717,876 8.1M
Low 1.1M n/a n/a

Revenue Growth

Revenue Growth 20242025202620272028
High
57.1%
-6.1%
2,664.4%
Avg
14.0%
-59.6%
1,030.8%
Low
-30.8%
- -

EPS Forecast

EPS 20242025202620272028
High -1.16 -0.39 -0.29
Avg -1.36 -0.76 -0.71
Low -1.51 -1.01 -0.99

EPS Growth

EPS Growth 20242025202620272028
High - - -
Avg - - -
Low - - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.